Before the Covid-19 pandemic struck, the U.S. was making some headway in fighting the drug overdose epidemic. But as the nation directs scarce public health resources to combatting Covid-19, the ...

Signing into law a change that can prevent thousands of Americans from dying of opioid overdoses should have been met with fanfare. Instead, it not only slid under the media radar but hasn’t been ...

Previously, doctors and other providers could prescribe buprenorphine only after they underwent separate training and received a waiver, called the “X-Waiver.” This year, the U.S. Department of Health ...

Rahul Gupta, M.D., director of the White House’s Office of National Drug Control Policy, speaks at a White House press event celebrating the elimination of the X-Waiver requirement. The policy change ...

The federal government loosened regulations for buprenorphine, but health experts warn that entrenched problems around training and access could stall efforts to get people the medication. By Noah ...

A significant provision expands pharmacists’ role in opioid use disorder treatment. This legislation reauthorizes programs related to substance use disorder prevention, treatment and recovery and ...

HHS on April 27 released new guidelines on prescribing practices for buprenorphine, a drug that treats opioid addiction and chronic pain. They allow most healthcare providers to prescribe the drug ...